Author

F. Ghaidi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

B. Zhai· 2 shared M. Daugaard· 2 shared P. H. Sorensen· 2 shared S. Truong· 2 shared A. Moeen· 1 shared A. Salanti· 1 shared C. C. Collins· 1 shared D. Brown· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Zhai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Conditional CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors

N. Khazamipour, H. Z. Oo, N. Al-Nakouzi, M. Marzban, N. Khazamipour, M. E. Robert, N. Farivar, I. Moskalev, J. Lo, F. Ghaidi, I. Nelepcu, A. Moeen, S. Truong, R. Dagil, S. Choudhary, , M. Daugaard

This study develops CAR T cells specific to oncofetal chondroitin sulfate, demonstrating their ability to target and eliminate tumor cells in vitro and improve survival in vivo.

bioRxiv · May 29, 2024 · PreprintCancer Biology

A bi-functional PARP-HDAC inhibitor with activity in Ewing sarcoma

L. Ramos, S. Truong, B. Zhai, J. Joshi, F. Ghaidi, M. M. Lizardo, T. Shyp, H. Adomat, S. LeBihan, C. C. Collins, J. Bacha, D. Brown, J. Langlands, W. Shen, N. Lallous, , M. Daugaard

This paper develops a dual PARP and HDAC inhibitor, kt-3283, showing enhanced cytotoxicity and efficacy in Ewing sarcoma models compared to single-agent inhibitors.

bioRxiv · Nov 10, 2022 · PreprintCancer Biology